ArticleEuropean thyroid journal2022

Rapid and long-lasting response to selpercatinib of paraneoplastic Cushing's syndrome in medullary thyroid carcinoma.

Marine Sitbon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.